Choosing a country will allow you to access local content and enable you to shop in your local currency.
IN Cell Analyzer systems are designed to deliver the throughput and performance you need for both High-Content Analysis (HCA) and High-Content Screening (HCS) of fixed and live cells.
This cutting edge technology gives you amazing depth and breadth of investigation, allowing you to simultaneously analyze morphological parameters, as well as multiple markers, within the same cell. With IN Cell Analyzer, analyze interactions as they happen and gain deeper insights into complex cellular mechanisms.
IN Cell system hardware and software combine to form a total solution for high content cellular analysis in research and drug discovery. Our systems enable a wide range of research and screening applications including multiplexed assays, secondary screening, and toxicity testing. In drug discovery, early insights on safety and efficacy lead to better decision-making about the most promising therapeutic candidates, saving valuable time and resources.
GE Healthcare's High Content Analysis (HCA) platform comprises a choice of two high-performance versatile imaging instruments, IN Cell Analyzer 2200 and IN Cell Analyzer 6000, to advance cellular understanding in applications such as drug discovery research. Both instruments are designed to give you a head start in HCA through features that allow you to get as much as possible from the available signal and to select the image quality, sensitivity, and speed that you need for your applications.
IN Carta image analysis software combines powerful analytics with a simple and intuitive interface enabling high-content analysis of images acquired on IN Cell Analyzer systems.
Image analysis software for IN Cell Analyzer systems. This powerful, yet flexible software offers three levels of analysis tools in a single platform to suit the varied complexity of different assay types as well as different user skill levels.
We've detected that you're using an unsupported browser.You may continue browsing, but for the best experience, please use Mozilla Firefox (v.30+), Google Chrome (v.35+) or Internet Explorer (v.11+).